February 10, 2016
Recommended Topic Related To:

Magnevist

"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.

GCTB generally occurs in a"...

A A A

Magnevist




Overdosage
Contraindications

OVERDOSE

Systemic consequences associated with overdosage of MAGNEVIST Injection have not been reported.

CONTRAINDICATIONS

MAGNEVIST is contraindicated in patients with:

  • Chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
  • Acute kidney injury.
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 4/11/2012

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.